Torrent Pharmaceuticals on Tuesday said it will launch MSD and Ridgeback’s molnupiravir under the brand name Molnutor in India for the treatment of COVID-19. Earlier this year, Torrent Pharma inked a non-exclusive voluntary licensing pact with MSD for manufacturing, distribution and marketing of Molnupiravir in more than 100 low-and middle-income markets, including India.
